Predicting Lung Cancer Recurrence with p185neu Protein Levels
Author Information
Author(s): M Diez, M PolIIan, M Maestro, A Torres, D Ortega, A G6mez, A Sanchez, F Hernando, JL Balibrea
Primary Institution: San Carlos University Hospital, Madrid; Carlos III Institute of Public Health, Madrid, Spain
Hypothesis
The study aims to determine the relationship between p185neu protein levels in lung cancer tissue and the risk of recurrence.
Conclusion
Higher levels of p185neu protein in lung cancer tissue are associated with an increased risk of recurrence after surgery.
Supporting Evidence
- The median concentration of p185 in tumor tissues was 206 U mg-1.
- Risk of recurrence increased by 1.304 for every increase of 100 units in p185 concentration.
- Cumulative likelihood of 3-year disease-free survival was 47%.
Takeaway
This study found that the more p185neu protein there is in lung cancer tissue, the more likely the cancer is to come back after treatment.
Methodology
The concentration of p185neu protein was measured in tumor samples from 94 patients using an enzyme immunoassay, and the relationship with recurrence was analyzed using Cox's proportional regression model.
Limitations
The study did not establish a clear diagnostic cut-off value for p185 levels.
Participant Demographics
The study included 94 patients with non-small-cell lung cancer, consisting of 85 men and 9 women, with a mean age of 62 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 1.141-1.490
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website